Literature DB >> 12517898

Prevalence of Candida species, including Candida dubliniensis, in Singapore.

C W Yang1, T M S Barkham, F Y Chan, Y Wang.   

Abstract

We present data on the prevalence of Candida species isolated from inpatients in three Singapore hospitals and from vaginal samples collected at community clinics. Strikingly, approximately 20% of the isolates from blood and vaginal samples were fluconazole-resistant species. By analyzing species-specific gene sequence signatures, we identified Candida dubliniensis from both groups of patients.

Entities:  

Mesh：

Year:  2003        PMID： 12517898      PMCID： PMC149596          DOI： 10.1128/JCM.41.1.472-474.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  27 in total

1.  Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro.

Authors:  G P Moran; D J Sullivan; M C Henman; C E McCreary; B J Harrington; D B Shanley; D C Coleman
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

2.  Secular trends in the epidemiology of nosocomial fungal infections at a teaching hospital in Taiwan, 1981 to 1993.

Authors:  Y C Chen; S C Chang; C C Sun; L S Yang; W C Hsieh; K T Luh
Journal:  Infect Control Hosp Epidemiol       Date:  1997-05       Impact factor: 3.254

3.  The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance.

Authors:  M H Nguyen; J E Peacock; A J Morris; D C Tanner; M L Nguyen; D R Snydman; M M Wagener; M G Rinaldi; V L Yu
Journal:  Am J Med       Date:  1996-06       Impact factor: 4.965

Review 4.  Epidemiology of nosocomial fungal infections, with emphasis on Candida species.

Authors:  W R Jarvis
Journal:  Clin Infect Dis       Date:  1995-06       Impact factor: 9.079

5.  Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System.

Authors:  C Beck-Sagué; W R Jarvis
Journal:  J Infect Dis       Date:  1993-05       Impact factor: 5.226

6.  Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals.

Authors:  D J Sullivan; T J Westerneng; K A Haynes; D E Bennett; D C Coleman
Journal:  Microbiology       Date:  1995-07       Impact factor: 2.777

7.  Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study Group.

Authors:  J H Rex; M A Pfaller; A L Barry; P W Nelson; C D Webb
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

8.  Rapid identification of yeast species using three primers in a polymerase chain reaction.

Authors:  J W Fell
Journal:  Mol Mar Biol Biotechnol       Date:  1993-06

9.  Use of fluconazole is not associated with a higher incidence of Candida krusei and other non-albicans Candida species.

Authors:  A Kunová; J Trupl; S Dluholucký; G Galová; V Krcméry
Journal:  Clin Infect Dis       Date:  1995-07       Impact factor: 9.079

Review 10.  Importance of Candida species other than C. albicans as pathogens in oncology patients.

Authors:  J R Wingard
Journal:  Clin Infect Dis       Date:  1995-01       Impact factor: 9.079
View more
  10 in total

1.  Use of denaturing high-performance liquid chromatography for rapid detection and identification of seven Candida species.

Authors:  Oliver Goldenberg; Stefanie Herrmann; Thomas Adam; Gina Marjoram; George Hong; Ulf B Göbel; Barbara Graf
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

Review 2.  Candida and invasive candidiasis: back to basics.

Authors:  C S-Y Lim; R Rosli; H F Seow; P P Chong
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-05-05       Impact factor: 3.267

Review 3.  Candida dubliniensis: epidemiology and phenotypic methods for identification.

Authors:  Erico Silva Loreto; Liliane A Scheid; Cristina W Nogueira; Gilson Zeni; Janio M Santurio; Sydney H Alves
Journal:  Mycopathologia       Date:  2010-02-21       Impact factor: 2.574

4.  Candidemia Among ICU Patients: Species Characterisation, Resistance Pattern and Association With Candida Score: A Prospective Study.

Authors:  Shabbir Ahmad; Shailesh Kumar; Kamlesh Rajpal; Richa Sinha; Rakesh Kumar; Sweta Muni; Namrata Kumari
Journal:  Cureus       Date:  2022-04-29

5.  Isolation of Candida dubliniensis for the first time in Cali, Colombia, and its identification with phenotyping methods.

Authors:  María Inés Alvarez; Blanca Lynne Suárez; Luz Dary Caicedo
Journal:  Mycopathologia       Date:  2008-07-12       Impact factor: 2.574

6.  Hypertonic sabouraud dextrose agar as a substrate for differentiation of Candida dubliniensis.

Authors:  Oncü Akgül; Nilgün Cerikçioğlu
Journal:  Mycopathologia       Date:  2009-02-20       Impact factor: 2.574

7.  Molecular identification of Candida orthopsilosis isolated from blood culture.

Authors:  P V C Yong; P P Chong; L Y Lau; R S C Yeoh; F Jamal
Journal:  Mycopathologia       Date:  2008-02-12       Impact factor: 2.574

8.  Anidulafungin compared with fluconazole in severely ill patients with candidemia and other forms of invasive candidiasis: support for the 2009 IDSA treatment guidelines for candidiasis.

Authors:  Daniel H Kett; Andrew F Shorr; Annette C Reboli; Arlene L Reisman; Pinaki Biswas; Haran T Schlamm
Journal:  Crit Care       Date:  2011-10-25       Impact factor: 9.097

9.  Prevalence and antifungal drug resistance of nosocomial Candida species isolated from two university hospitals in Egypt.

Authors:  Amira M El-Ganiny; Nehal E Yossef; Hend A Kamel
Journal:  Curr Med Mycol       Date:  2021-03

10.  Correlation between antifungal consumption and the distribution of Candida species in different hospital departments of a Lebanese medical Centre.

Authors:  Lyn Awad; Hani Tamim; Dania Abdallah; Mohammad Salameh; Anas Mugharbil; Tamima Jisr; Kamal Zahran; Nabila Droubi; Ahmad Ibrahim; Rima Moghnieh
Journal:  BMC Infect Dis       Date:  2018-11-20       Impact factor: 3.090
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.